722680009: Primary serous adenocarcinoma of endometrium (disorder)

SNOMED CT Concept\Clinical finding (finding)\...

\Viscus structure finding (finding)\Abdominal organ finding\...

\Pelvic organ finding (finding)\Uterus finding\...

\Mass of uterus\Neoplasm of uterus\...

\Malignant neoplasm of uterus (disorder)\Primary malignant neoplasm of uterus\Primary malignant neoplasm of body of uterus (disorder)\Primary malignant neoplasm of endometrium\Primary serous adenocarcinoma of endometrium (disorder)
\Malignant neoplasm of uterus (disorder)\Malignant neoplasm of body of uterus (disorder)\A rare high-grade endometrial carcinoma characterized by diffuse, marked nuclear pleomorphism, typically exhibiting complex papillary and/or glandular growth patterns and showing abnormal p53 and diffuse p16 immunohistochemistry. The tumor typically arises in atrophic endometrium or in an endometrial polyp. Most patients present with postmenopausal bleeding. Extrauterine metastasis is present in 40-50% of surgically staged cases, most frequently involving lymph nodes or peritoneal sites and omentum. Patients with extrauterine spread have poor outcomes, while endometrium-limited carcinoma has a better prognosis.\Primary serous adenocarcinoma of endometrium (disorder)
\Malignant neoplasm of uterus (disorder)\Malignant neoplasm of body of uterus (disorder)\Primary malignant neoplasm of body of uterus (disorder)\Primary malignant neoplasm of endometrium\Primary serous adenocarcinoma of endometrium (disorder)
\Malignant neoplasm of uterus (disorder)\Malignant neoplasm of body of uterus (disorder)\Malignant neoplasm of endometrium of corpus uteri\Primary malignant neoplasm of endometrium\Primary serous adenocarcinoma of endometrium (disorder)

\Neoplasm of body of uterus\Malignant neoplasm of body of uterus (disorder)\A rare high-grade endometrial carcinoma characterized by diffuse, marked nuclear pleomorphism, typically exhibiting complex papillary and/or glandular growth patterns and showing abnormal p53 and diffuse p16 immunohistochemistry. The tumor typically arises in atrophic endometrium or in an endometrial polyp. Most patients present with postmenopausal bleeding. Extrauterine metastasis is present in 40-50% of surgically staged cases, most frequently involving lymph nodes or peritoneal sites and omentum. Patients with extrauterine spread have poor outcomes, while endometrium-limited carcinoma has a better prognosis.\Primary serous adenocarcinoma of endometrium (disorder)
\Neoplasm of body of uterus\Malignant neoplasm of body of uterus (disorder)\Primary malignant neoplasm of body of uterus (disorder)\Primary malignant neoplasm of endometrium\Primary serous adenocarcinoma of endometrium (disorder)
\Neoplasm of body of uterus\Malignant neoplasm of body of uterus (disorder)\Malignant neoplasm of endometrium of corpus uteri\Primary malignant neoplasm of endometrium\Primary serous adenocarcinoma of endometrium (disorder)
\Neoplasm of body of uterus\Neoplasm of endometrium\Malignant neoplasm of endometrium of corpus uteri\Primary malignant neoplasm of endometrium\Primary serous adenocarcinoma of endometrium (disorder)

\Body of uterus finding (finding)\Endometrial disorder\Lesion of endometrium (disorder)\Neoplasm of endometrium\Malignant neoplasm of endometrium of corpus uteri\Primary malignant neoplasm of endometrium\Primary serous adenocarcinoma of endometrium (disorder)
\Body of uterus finding (finding)\Neoplasm of body of uterus\Malignant neoplasm of body of uterus (disorder)\A rare high-grade endometrial carcinoma characterized by diffuse, marked nuclear pleomorphism, typically exhibiting complex papillary and/or glandular growth patterns and showing abnormal p53 and diffuse p16 immunohistochemistry. The tumor typically arises in atrophic endometrium or in an endometrial polyp. Most patients present with postmenopausal bleeding. Extrauterine metastasis is present in 40-50% of surgically staged cases, most frequently involving lymph nodes or peritoneal sites and omentum. Patients with extrauterine spread have poor outcomes, while endometrium-limited carcinoma has a better prognosis.\Primary serous adenocarcinoma of endometrium (disorder)
\Body of uterus finding (finding)\Neoplasm of body of uterus\Malignant neoplasm of body of uterus (disorder)\Primary malignant neoplasm of body of uterus (disorder)\Primary malignant neoplasm of endometrium\Primary serous adenocarcinoma of endometrium (disorder)
\Body of uterus finding (finding)\Neoplasm of body of uterus\Malignant neoplasm of body of uterus (disorder)\Malignant neoplasm of endometrium of corpus uteri\Primary malignant neoplasm of endometrium\Primary serous adenocarcinoma of endometrium (disorder)
\Body of uterus finding (finding)\Neoplasm of body of uterus\Neoplasm of endometrium\Malignant neoplasm of endometrium of corpus uteri\Primary malignant neoplasm of endometrium\Primary serous adenocarcinoma of endometrium (disorder)

\Disorder of uterus\Endometrial disorder\Lesion of endometrium (disorder)\Neoplasm of endometrium\Malignant neoplasm of endometrium of corpus uteri\Primary malignant neoplasm of endometrium\Primary serous adenocarcinoma of endometrium (disorder)
\Disorder of uterus\Lesion of uterus (disorder)\Lesion of endometrium (disorder)\Neoplasm of endometrium\Malignant neoplasm of endometrium of corpus uteri\Primary malignant neoplasm of endometrium\Primary serous adenocarcinoma of endometrium (disorder)
\Disorder of uterus\Lesion of uterus (disorder)\Neoplasm of uterus\Malignant neoplasm of uterus (disorder)\Primary malignant neoplasm of uterus\Primary malignant neoplasm of body of uterus (disorder)\Primary malignant neoplasm of endometrium\Primary serous adenocarcinoma of endometrium (disorder)
\Disorder of uterus\Lesion of uterus (disorder)\Neoplasm of uterus\Malignant neoplasm of uterus (disorder)\Malignant neoplasm of body of uterus (disorder)\A rare high-grade endometrial carcinoma characterized by diffuse, marked nuclear pleomorphism, typically exhibiting complex papillary and/or glandular growth patterns and showing abnormal p53 and diffuse p16 immunohistochemistry. The tumor typically arises in atrophic endometrium or in an endometrial polyp. Most patients present with postmenopausal bleeding. Extrauterine metastasis is present in 40-50% of surgically staged cases, most frequently involving lymph nodes or peritoneal sites and omentum. Patients with extrauterine spread have poor outcomes, while endometrium-limited carcinoma has a better prognosis.\Primary serous adenocarcinoma of endometrium (disorder)
\Disorder of uterus\Lesion of uterus (disorder)\Neoplasm of uterus\Malignant neoplasm of uterus (disorder)\Malignant neoplasm of body of uterus (disorder)\Primary malignant neoplasm of body of uterus (disorder)\Primary malignant neoplasm of endometrium\Primary serous adenocarcinoma of endometrium (disorder)
\Disorder of uterus\Lesion of uterus (disorder)\Neoplasm of uterus\Malignant neoplasm of uterus (disorder)\Malignant neoplasm of body of uterus (disorder)\Malignant neoplasm of endometrium of corpus uteri\Primary malignant neoplasm of endometrium\Primary serous adenocarcinoma of endometrium (disorder)
\Disorder of uterus\Lesion of uterus (disorder)\Neoplasm of uterus\Neoplasm of body of uterus\Malignant neoplasm of body of uterus (disorder)\A rare high-grade endometrial carcinoma characterized by diffuse, marked nuclear pleomorphism, typically exhibiting complex papillary and/or glandular growth patterns and showing abnormal p53 and diffuse p16 immunohistochemistry. The tumor typically arises in atrophic endometrium or in an endometrial polyp. Most patients present with postmenopausal bleeding. Extrauterine metastasis is present in 40-50% of surgically staged cases, most frequently involving lymph nodes or peritoneal sites and omentum. Patients with extrauterine spread have poor outcomes, while endometrium-limited carcinoma has a better prognosis.\Primary serous adenocarcinoma of endometrium (disorder)
\Disorder of uterus\Lesion of uterus (disorder)\Neoplasm of uterus\Neoplasm of body of uterus\Malignant neoplasm of body of uterus (disorder)\Primary malignant neoplasm of body of uterus (disorder)\Primary malignant neoplasm of endometrium\Primary serous adenocarcinoma of endometrium (disorder)
\Disorder of uterus\Lesion of uterus (disorder)\Neoplasm of uterus\Neoplasm of body of uterus\Malignant neoplasm of body of uterus (disorder)\Malignant neoplasm of endometrium of corpus uteri\Primary malignant neoplasm of endometrium\Primary serous adenocarcinoma of endometrium (disorder)
\Disorder of uterus\Lesion of uterus (disorder)\Neoplasm of uterus\Neoplasm of body of uterus\Neoplasm of endometrium\Malignant neoplasm of endometrium of corpus uteri\Primary malignant neoplasm of endometrium\Primary serous adenocarcinoma of endometrium (disorder)

\Neoplasm of intra-abdominal organs\Malignant neoplasm of intraabdominal organ (disorder)\Malignant neoplasm of uterus (disorder)\Primary malignant neoplasm of uterus\Primary malignant neoplasm of body of uterus (disorder)\Primary malignant neoplasm of endometrium\Primary serous adenocarcinoma of endometrium (disorder)
\Neoplasm of intra-abdominal organs\Malignant neoplasm of intraabdominal organ (disorder)\Malignant neoplasm of uterus (disorder)\Malignant neoplasm of body of uterus (disorder)\A rare high-grade endometrial carcinoma characterized by diffuse, marked nuclear pleomorphism, typically exhibiting complex papillary and/or glandular growth patterns and showing abnormal p53 and diffuse p16 immunohistochemistry. The tumor typically arises in atrophic endometrium or in an endometrial polyp. Most patients present with postmenopausal bleeding. Extrauterine metastasis is present in 40-50% of surgically staged cases, most frequently involving lymph nodes or peritoneal sites and omentum. Patients with extrauterine spread have poor outcomes, while endometrium-limited carcinoma has a better prognosis.\Primary serous adenocarcinoma of endometrium (disorder)
\Neoplasm of intra-abdominal organs\Malignant neoplasm of intraabdominal organ (disorder)\Malignant neoplasm of uterus (disorder)\Malignant neoplasm of body of uterus (disorder)\Primary malignant neoplasm of body of uterus (disorder)\Primary malignant neoplasm of endometrium\Primary serous adenocarcinoma of endometrium (disorder)
\Neoplasm of intra-abdominal organs\Malignant neoplasm of intraabdominal organ (disorder)\Malignant neoplasm of uterus (disorder)\Malignant neoplasm of body of uterus (disorder)\Malignant neoplasm of endometrium of corpus uteri\Primary malignant neoplasm of endometrium\Primary serous adenocarcinoma of endometrium (disorder)
\Neoplasm of intra-abdominal organs\Malignant neoplasm of intraabdominal organ (disorder)\Primary malignant neoplasm of intra-abdominal organs\Primary malignant neoplasm of uterus\Primary malignant neoplasm of body of uterus (disorder)\Primary malignant neoplasm of endometrium\Primary serous adenocarcinoma of endometrium (disorder)
\Neoplasm of intra-abdominal organs\Neoplasm of uterus\Malignant neoplasm of uterus (disorder)\Primary malignant neoplasm of uterus\Primary malignant neoplasm of body of uterus (disorder)\Primary malignant neoplasm of endometrium\Primary serous adenocarcinoma of endometrium (disorder)
\Neoplasm of intra-abdominal organs\Neoplasm of uterus\Malignant neoplasm of uterus (disorder)\Malignant neoplasm of body of uterus (disorder)\A rare high-grade endometrial carcinoma characterized by diffuse, marked nuclear pleomorphism, typically exhibiting complex papillary and/or glandular growth patterns and showing abnormal p53 and diffuse p16 immunohistochemistry. The tumor typically arises in atrophic endometrium or in an endometrial polyp. Most patients present with postmenopausal bleeding. Extrauterine metastasis is present in 40-50% of surgically staged cases, most frequently involving lymph nodes or peritoneal sites and omentum. Patients with extrauterine spread have poor outcomes, while endometrium-limited carcinoma has a better prognosis.\Primary serous adenocarcinoma of endometrium (disorder)
\Neoplasm of intra-abdominal organs\Neoplasm of uterus\Malignant neoplasm of uterus (disorder)\Malignant neoplasm of body of uterus (disorder)\Primary malignant neoplasm of body of uterus (disorder)\Primary malignant neoplasm of endometrium\Primary serous adenocarcinoma of endometrium (disorder)
\Neoplasm of intra-abdominal organs\Neoplasm of uterus\Malignant neoplasm of uterus (disorder)\Malignant neoplasm of body of uterus (disorder)\Malignant neoplasm of endometrium of corpus uteri\Primary malignant neoplasm of endometrium\Primary serous adenocarcinoma of endometrium (disorder)
\Neoplasm of intra-abdominal organs\Neoplasm of uterus\Neoplasm of body of uterus\Malignant neoplasm of body of uterus (disorder)\A rare high-grade endometrial carcinoma characterized by diffuse, marked nuclear pleomorphism, typically exhibiting complex papillary and/or glandular growth patterns and showing abnormal p53 and diffuse p16 immunohistochemistry. The tumor typically arises in atrophic endometrium or in an endometrial polyp. Most patients present with postmenopausal bleeding. Extrauterine metastasis is present in 40-50% of surgically staged cases, most frequently involving lymph nodes or peritoneal sites and omentum. Patients with extrauterine spread have poor outcomes, while endometrium-limited carcinoma has a better prognosis.\Primary serous adenocarcinoma of endometrium (disorder)
\Neoplasm of intra-abdominal organs\Neoplasm of uterus\Neoplasm of body of uterus\Malignant neoplasm of body of uterus (disorder)\Primary malignant neoplasm of body of uterus (disorder)\Primary malignant neoplasm of endometrium\Primary serous adenocarcinoma of endometrium (disorder)
\Neoplasm of intra-abdominal organs\Neoplasm of uterus\Neoplasm of body of uterus\Malignant neoplasm of body of uterus (disorder)\Malignant neoplasm of endometrium of corpus uteri\Primary malignant neoplasm of endometrium\Primary serous adenocarcinoma of endometrium (disorder)
\Neoplasm of intra-abdominal organs\Neoplasm of uterus\Neoplasm of body of uterus\Neoplasm of endometrium\Malignant neoplasm of endometrium of corpus uteri\Primary malignant neoplasm of endometrium\Primary serous adenocarcinoma of endometrium (disorder)

\Mass of body structure\Mass of body region (finding)\Mass of trunk (finding)\...

\Pelvic mass\Mass of uterus\Neoplasm of uterus\Malignant neoplasm of uterus (disorder)\Primary malignant neoplasm of uterus\Primary malignant neoplasm of body of uterus (disorder)\Primary malignant neoplasm of endometrium\Primary serous adenocarcinoma of endometrium (disorder)
\Pelvic mass\Mass of uterus\Neoplasm of uterus\Malignant neoplasm of uterus (disorder)\Malignant neoplasm of body of uterus (disorder)\A rare high-grade endometrial carcinoma characterized by diffuse, marked nuclear pleomorphism, typically exhibiting complex papillary and/or glandular growth patterns and showing abnormal p53 and diffuse p16 immunohistochemistry. The tumor typically arises in atrophic endometrium or in an endometrial polyp. Most patients present with postmenopausal bleeding. Extrauterine metastasis is present in 40-50% of surgically staged cases, most frequently involving lymph nodes or peritoneal sites and omentum. Patients with extrauterine spread have poor outcomes, while endometrium-limited carcinoma has a better prognosis.\Primary serous adenocarcinoma of endometrium (disorder)
\Pelvic mass\Mass of uterus\Neoplasm of uterus\Malignant neoplasm of uterus (disorder)\Malignant neoplasm of body of uterus (disorder)\Primary malignant neoplasm of body of uterus (disorder)\Primary malignant neoplasm of endometrium\Primary serous adenocarcinoma of endometrium (disorder)
\Pelvic mass\Mass of uterus\Neoplasm of uterus\Malignant neoplasm of uterus (disorder)\Malignant neoplasm of body of uterus (disorder)\Malignant neoplasm of endometrium of corpus uteri\Primary malignant neoplasm of endometrium\Primary serous adenocarcinoma of endometrium (disorder)
\Pelvic mass\Mass of uterus\Neoplasm of uterus\Neoplasm of body of uterus\Malignant neoplasm of body of uterus (disorder)\A rare high-grade endometrial carcinoma characterized by diffuse, marked nuclear pleomorphism, typically exhibiting complex papillary and/or glandular growth patterns and showing abnormal p53 and diffuse p16 immunohistochemistry. The tumor typically arises in atrophic endometrium or in an endometrial polyp. Most patients present with postmenopausal bleeding. Extrauterine metastasis is present in 40-50% of surgically staged cases, most frequently involving lymph nodes or peritoneal sites and omentum. Patients with extrauterine spread have poor outcomes, while endometrium-limited carcinoma has a better prognosis.\Primary serous adenocarcinoma of endometrium (disorder)
\Pelvic mass\Mass of uterus\Neoplasm of uterus\Neoplasm of body of uterus\Malignant neoplasm of body of uterus (disorder)\Primary malignant neoplasm of body of uterus (disorder)\Primary malignant neoplasm of endometrium\Primary serous adenocarcinoma of endometrium (disorder)
\Pelvic mass\Mass of uterus\Neoplasm of uterus\Neoplasm of body of uterus\Malignant neoplasm of body of uterus (disorder)\Malignant neoplasm of endometrium of corpus uteri\Primary malignant neoplasm of endometrium\Primary serous adenocarcinoma of endometrium (disorder)
\Pelvic mass\Mass of uterus\Neoplasm of uterus\Neoplasm of body of uterus\Neoplasm of endometrium\Malignant neoplasm of endometrium of corpus uteri\Primary malignant neoplasm of endometrium\Primary serous adenocarcinoma of endometrium (disorder)
\Pelvic mass\Neoplasm of pelvis (disorder)\Malignant tumor of pelvis\Malignant neoplasm of uterus (disorder)\Primary malignant neoplasm of uterus\Primary malignant neoplasm of body of uterus (disorder)\Primary malignant neoplasm of endometrium\Primary serous adenocarcinoma of endometrium (disorder)
\Pelvic mass\Neoplasm of pelvis (disorder)\Malignant tumor of pelvis\Malignant neoplasm of uterus (disorder)\Malignant neoplasm of body of uterus (disorder)\A rare high-grade endometrial carcinoma characterized by diffuse, marked nuclear pleomorphism, typically exhibiting complex papillary and/or glandular growth patterns and showing abnormal p53 and diffuse p16 immunohistochemistry. The tumor typically arises in atrophic endometrium or in an endometrial polyp. Most patients present with postmenopausal bleeding. Extrauterine metastasis is present in 40-50% of surgically staged cases, most frequently involving lymph nodes or peritoneal sites and omentum. Patients with extrauterine spread have poor outcomes, while endometrium-limited carcinoma has a better prognosis.\Primary serous adenocarcinoma of endometrium (disorder)
\Pelvic mass\Neoplasm of pelvis (disorder)\Malignant tumor of pelvis\Malignant neoplasm of uterus (disorder)\Malignant neoplasm of body of uterus (disorder)\Primary malignant neoplasm of body of uterus (disorder)\Primary malignant neoplasm of endometrium\Primary serous adenocarcinoma of endometrium (disorder)
\Pelvic mass\Neoplasm of pelvis (disorder)\Malignant tumor of pelvis\Malignant neoplasm of uterus (disorder)\Malignant neoplasm of body of uterus (disorder)\Malignant neoplasm of endometrium of corpus uteri\Primary malignant neoplasm of endometrium\Primary serous adenocarcinoma of endometrium (disorder)
\Pelvic mass\Neoplasm of pelvis (disorder)\Malignant tumor of pelvis\Primary malignant neoplasm of pelvis (disorder)\Primary malignant neoplasm of uterus\Primary malignant neoplasm of body of uterus (disorder)\Primary malignant neoplasm of endometrium\Primary serous adenocarcinoma of endometrium (disorder)
\Pelvic mass\Neoplasm of pelvis (disorder)\Neoplasm of uterus\Malignant neoplasm of uterus (disorder)\Primary malignant neoplasm of uterus\Primary malignant neoplasm of body of uterus (disorder)\Primary malignant neoplasm of endometrium\Primary serous adenocarcinoma of endometrium (disorder)
\Pelvic mass\Neoplasm of pelvis (disorder)\Neoplasm of uterus\Malignant neoplasm of uterus (disorder)\Malignant neoplasm of body of uterus (disorder)\A rare high-grade endometrial carcinoma characterized by diffuse, marked nuclear pleomorphism, typically exhibiting complex papillary and/or glandular growth patterns and showing abnormal p53 and diffuse p16 immunohistochemistry. The tumor typically arises in atrophic endometrium or in an endometrial polyp. Most patients present with postmenopausal bleeding. Extrauterine metastasis is present in 40-50% of surgically staged cases, most frequently involving lymph nodes or peritoneal sites and omentum. Patients with extrauterine spread have poor outcomes, while endometrium-limited carcinoma has a better prognosis.\Primary serous adenocarcinoma of endometrium (disorder)
\Pelvic mass\Neoplasm of pelvis (disorder)\Neoplasm of uterus\Malignant neoplasm of uterus (disorder)\Malignant neoplasm of body of uterus (disorder)\Primary malignant neoplasm of body of uterus (disorder)\Primary malignant neoplasm of endometrium\Primary serous adenocarcinoma of endometrium (disorder)
\Pelvic mass\Neoplasm of pelvis (disorder)\Neoplasm of uterus\Malignant neoplasm of uterus (disorder)\Malignant neoplasm of body of uterus (disorder)\Malignant neoplasm of endometrium of corpus uteri\Primary malignant neoplasm of endometrium\Primary serous adenocarcinoma of endometrium (disorder)
\Pelvic mass\Neoplasm of pelvis (disorder)\Neoplasm of uterus\Neoplasm of body of uterus\Malignant neoplasm of body of uterus (disorder)\A rare high-grade endometrial carcinoma characterized by diffuse, marked nuclear pleomorphism, typically exhibiting complex papillary and/or glandular growth patterns and showing abnormal p53 and diffuse p16 immunohistochemistry. The tumor typically arises in atrophic endometrium or in an endometrial polyp. Most patients present with postmenopausal bleeding. Extrauterine metastasis is present in 40-50% of surgically staged cases, most frequently involving lymph nodes or peritoneal sites and omentum. Patients with extrauterine spread have poor outcomes, while endometrium-limited carcinoma has a better prognosis.\Primary serous adenocarcinoma of endometrium (disorder)
\Pelvic mass\Neoplasm of pelvis (disorder)\Neoplasm of uterus\Neoplasm of body of uterus\Malignant neoplasm of body of uterus (disorder)\Primary malignant neoplasm of body of uterus (disorder)\Primary malignant neoplasm of endometrium\Primary serous adenocarcinoma of endometrium (disorder)
\Pelvic mass\Neoplasm of pelvis (disorder)\Neoplasm of uterus\Neoplasm of body of uterus\Malignant neoplasm of body of uterus (disorder)\Malignant neoplasm of endometrium of corpus uteri\Primary malignant neoplasm of endometrium\Primary serous adenocarcinoma of endometrium (disorder)
\Pelvic mass\Neoplasm of pelvis (disorder)\Neoplasm of uterus\Neoplasm of body of uterus\Neoplasm of endometrium\Malignant neoplasm of endometrium of corpus uteri\Primary malignant neoplasm of endometrium\Primary serous adenocarcinoma of endometrium (disorder)

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2017. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Primary serous adenocarcinoma of endometrium (disorder)	Is a	Primary malignant neoplasm of endometrium	true	Inferred relationship	Existential restriction modifier (core metadata concept)
Primary serous adenocarcinoma of endometrium (disorder)	Is a	Adenocarcinoma of endometrium	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Primary serous adenocarcinoma of endometrium (disorder)	Is a	Primary adenocarcinoma of pelvis	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Primary serous adenocarcinoma of endometrium (disorder)	Associated morphology	Serous cystadenocarcinoma	true	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Primary serous adenocarcinoma of endometrium (disorder)	Finding site	Endometrial structure	true	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Primary serous adenocarcinoma of endometrium (disorder)	Is a	A rare high-grade endometrial carcinoma characterized by diffuse, marked nuclear pleomorphism, typically exhibiting complex papillary and/or glandular growth patterns and showing abnormal p53 and diffuse p16 immunohistochemistry. The tumor typically arises in atrophic endometrium or in an endometrial polyp. Most patients present with postmenopausal bleeding. Extrauterine metastasis is present in 40-50% of surgically staged cases, most frequently involving lymph nodes or peritoneal sites and omentum. Patients with extrauterine spread have poor outcomes, while endometrium-limited carcinoma has a better prognosis.	true	Inferred relationship	Existential restriction modifier (core metadata concept)
Primary serous adenocarcinoma of endometrium (disorder)	Pathological process (attribute)	Malignant proliferation of primary neoplasm (qualifier value)	true	Inferred relationship	Existential restriction modifier (core metadata concept)	1

Inbound Relationships

Type

Active

Source

Characteristic

Refinability

Group

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
3333067012	Primary serous adenocarcinoma of endometrium (disorder)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3333068019	Primary serous adenocarcinoma of endometrium	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3333069010	Primary endometrial serous adenocarcinoma	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3852376016	Primary papillary serous cystadenocarcinoma of endometrium	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3333067012	Primary serous adenocarcinoma of endometrium (disorder)	en	Fully specified name	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
3333067012	Primary serous adenocarcinoma of endometrium (disorder)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3333068019	Primary serous adenocarcinoma of endometrium	en	Synonym (core metadata concept)	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
3333068019	Primary serous adenocarcinoma of endometrium	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3333069010	Primary endometrial serous adenocarcinoma	en	Synonym (core metadata concept)	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
3333069010	Primary endometrial serous adenocarcinoma	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3852376016	Primary papillary serous cystadenocarcinoma of endometrium	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
5936631000241116	adénocarcinome endométrial séreux primitif	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
5936641000241114	adénocarcinome primitif des glandes séreuses de l'endomètre	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
5936651000241112	adénocarcinome séreux primitif de l'endomètre	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
5936631000241116	adénocarcinome endométrial séreux primitif	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
5936641000241114	adénocarcinome primitif des glandes séreuses de l'endomètre	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
5936651000241112	adénocarcinome séreux primitif de l'endomètre	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module